Barlier A, Zamora A J, Grino M, Gunz G, Pellegrini-Bouiller I, Morange-Ramos I, Figarella-Branger D, Dufour H, Jaquet P, Enjalbert A
Laboratoire Interactions Cellulaires Neuroendocriniennes, UMR 6544, CNRS-Université de la Méditerranée, Institut Fédératif Jean-Roche, Faculté de Médecine Nord, Marseille, France.
J Neuroendocrinol. 1999 Jul;11(7):491-502. doi: 10.1046/j.1365-2826.1999.00351.x.
We examined the expression of functional growth hormone secretagogue receptors (GHS-R) in a series of 30 human pituitary adenomas-six secreting GH, three GH-PRL, six prolactin (PRL), five adrenocorticotrophic hormone (ACTH), one thyroid stimulating hormone (TSH), four gonadotroph and five non-secreting adenomas. By reverse transcriptase polymerase chain reaction (RT-PCR), the coexpression of the two GHS-R isoforms (Ia and Ib) was found in all the GH-, GH-PRL- and PRL-secreting adenomas, and only in two out of three corticotroph, two out of four gonadotroph and one out of five non-secreting tumours. They were absent in the TSH-secreting adenoma. The PCR products of GHS-R Ia and Ib were identical in size to those from two normal pituitaries. PCR cloning and sequencing of isoforms performed in two somatotroph adenomas revealed only two single, silent base mutations. Triple in-situ hybridization showed colocalization of GHS-R mRNA with messengers of GH and PRL, conjointly or separately, in individual cells of somatotroph, mammosomatotroph, and lactotroph adenomas. The presence of GHS-R mRNA in cells expressing PRL mRNA is emphasized. In cultured cells from six somatotroph and two mammosomatotroph adenomas, the powerful GHS MK-0677 stimulated GH release in a dose-dependent manner, with maximal effect at 6 h. Contrarily, when GHRH was applied, only three somatotrophs and two mamosomatotrophs were stimulated. In the two mammosomatotrophs, the PRL response to MK-0677 and to GHRH was similar to the GH response. An homologous desensitization of the GHS-R and the GHRH receptor was observed 24 h after a first stimulation by a single dose of the corresponding agonist. Heterologous desensitization was not observed. Interestingly, MK-0677 also stimulated, in a dose-dependent way, the hormone release of cells from all tested lactotroph and corticotroph adenomas. The existence of a functional expression of GHS-R in somatotroph, mammosomatotroph, lactotroph and corticotroph adenomas rises the question of the role played by GHS-R in pituitary adenomas, particularly those not engaged in GH secretion.
我们检测了30例人类垂体腺瘤中功能性生长激素促分泌素受体(GHS-R)的表达,其中6例分泌生长激素(GH),3例分泌GH-泌乳素(PRL),6例分泌泌乳素(PRL),5例分泌促肾上腺皮质激素(ACTH),1例分泌促甲状腺激素(TSH),4例促性腺激素腺瘤以及5例无分泌功能的腺瘤。通过逆转录聚合酶链反应(RT-PCR)发现,在所有分泌GH、GH-PRL和PRL的腺瘤中均存在两种GHS-R亚型(Ia和Ib)的共表达,而在3例促肾上腺皮质激素腺瘤中的2例、4例促性腺激素腺瘤中的2例以及5例无分泌功能肿瘤中的1例中也有共表达。在分泌TSH的腺瘤中未检测到它们的表达。GHS-R Ia和Ib的PCR产物大小与来自两个正常垂体的产物相同。对两个生长激素腺瘤进行的亚型PCR克隆和测序仅发现两个单一的沉默碱基突变。三重原位杂交显示,在生长激素细胞腺瘤、生长泌乳细胞腺瘤和泌乳细胞腺瘤的单个细胞中,GHS-R mRNA与GH和PRL的信使RNA共同或分别共定位。强调了在表达PRL mRNA的细胞中存在GHS-R mRNA。在来自6例生长激素细胞腺瘤和2例生长泌乳细胞腺瘤的培养细胞中,强效GHS MK-0677以剂量依赖方式刺激GH释放,在6小时时达到最大效应。相反,当应用生长激素释放激素(GHRH)时,仅3例生长激素细胞和2例生长泌乳细胞受到刺激。在这2例生长泌乳细胞中,PRL对MK-0677和GHRH的反应与GH反应相似。在单次给予相应激动剂进行首次刺激24小时后,观察到GHS-R和GHRH受体的同源脱敏。未观察到异源脱敏。有趣的是,MK-0677还以剂量依赖方式刺激了所有测试的泌乳细胞和促肾上腺皮质激素腺瘤细胞的激素释放。生长激素细胞腺瘤、生长泌乳细胞腺瘤、泌乳细胞腺瘤和促肾上腺皮质激素腺瘤中GHS-R的功能性表达的存在,引发了GHS-R在垂体腺瘤中所起作用的问题,特别是那些不参与GH分泌的腺瘤。